PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
12-Mar-2021 Creative Diagnostics Introduces Iron Oxide Nanorods for Research Applications Creative Diagnostics
12-Mar-2021 Healthcare 3D Printing Market To Grow At 18% CAGR Market Data Forecast
11-Mar-2021 Orgenesis enters second phase of collaboration with Hospital Infantil Universitario Niño Jesús in Madrid with exclusive license to commercialize Celyvir solid tumor therapy Orgenesis
11-Mar-2021 Kite, a Gilead Company, to share latest scientific advances in cell therapy research at the 47th Virtual Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) Kite, a Gilead Company
11-Mar-2021 Significant milestones achieved on all drug candidates in 2020 and financial visibility until 2022 Transgene
10-Mar-2021 Focus on Emergex Emergex
10-Mar-2021 AELIX Therapeutics presents positive results from randomized placebo-controlled phase I/IIa therapeutic HIV vaccine clinical trial Andrew Lloyd Associates
10-Mar-2021 Lynne Ensor, Parexel Chair of SMi’s 4th Annual Pharmaceutical Microbiology East Coast Conference, exclusive interview released SMi Group
10-Mar-2021 eXmoor pharma secures £12m ($17m) from healthcare investment firm MVM marking milestone towards significant expansion plans eXmoor Pharma
10-Mar-2021 Immutep Secures Second United States Patent Grant for Eftilagimod Alpha in Combination with a PD-1 Pathway Inhibitor Immutep
10-Mar-2021 Orgenesis Mobile Processing Units and Labs (OMPULs) to be Used for Point-of-Care Production and Commercialization of Cell and Gene Therapies in Collaboration with Dong-a University Hospital and Cure Therapeutics in South Korea Orgenesis Inc.
10-Mar-2021 NeoPhore Announces £15.2m Financing to Advance DNA Mismatch Repair Pipeline NeoPhore Limited
10-Mar-2021 ExeVir Bio Announces New Publication from VIB Scientists Showing Potent and Broad Neutralizing Activity and Infection Protection Against SARS-COV, its Variants of Concern and Related Coronaviruses ExeVir Bio
10-Mar-2021 Arix founds new portfolio company Twelve Bio Arix Bioscience plc
10-Mar-2021 Advent France Biotechnology participe au tour de table de Série B de 74M$ (61,5M€) d’AgomAb Therapeutics Andrew Lloyd Associates
10-Mar-2021 Uni-Bio Science Group and DotBio Announce Partnership to Co-Develop multi-specific DotBodies for people with retinal diseases DotBio Pte Ltd
09-Mar-2021 CPhI Report forecasts explosion of contract services growth due to surging INDs and 75 FDA approvals by 2025 CPhI
09-Mar-2021 Polyplus-transfection acquires Biowire to further expand into Asia-Pacific gene and cell therapy markets Polyplus-transfection® SA,
09-Mar-2021 Pneumagen Announces Neumifil™ is Efficacious In an Established Model of COVID-19 Infection Pneumagen
09-Mar-2021 Tollys welcomes Dr. Jean-Pierre Armand as member of its scientific advisory board Andrew Lloyd Associates